Illumina (ILMN) closed yesterday (02012.03.28) at $49.88. 52-week range: $25.57 - $79.40. Roche's initial offer was $44.50 and their new offer is $51. I don't want sell our ILMN shares at $51 because I think they are worth more than that; therefore, this is potentially bad news because other investors might disagree with my opinion and be happy cashing out at $51. I continue to believe Roche is trying to buy Illumina on the cheap.
No comments:
Post a Comment